STOCK TITAN

BIO-key (NASDAQ: BKYI) forecasts 50% 1H 2026 revenue rise and profit

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

BIO-key International outlined a strong outlook for the first half of 2026, expecting a 50% increase in first-half revenues and profitability for the period ending June 30, 2026. This improvement is driven by building software license momentum and stronger hardware sales.

The company highlighted a one-year software license renewal with a longstanding foreign retail bank and more than $1M in contracts for Pocket 10 Finger Scanners and Mobile POS Pro devices across the first two quarters. Management also pointed to larger biometric authentication opportunities with foreign government agencies and regulated enterprises, supported by a growing base of annually recurring software and services revenues.

Positive

  • Guides to 50% first-half 2026 revenue growth and profitability, supported by recurring software licenses and more than $1M in hardware contracts, indicating a potential shift from historical losses toward sustainable earnings.

Negative

  • None.

Insights

BIO-key guides to 50% 1H 2026 revenue growth and profitability.

BIO-key International is signaling a material turnaround by forecasting a 50% increase in first-half 2026 revenues and profitability. The outlook is backed by a one-year software license renewal with a foreign retail bank and more than $1M in hardware contracts.

The mix of expanding recurring software licenses and sizable hardware orders suggests more diversified revenue. Management also cites potential deployments with a foreign tax agency and a foreign defense ministry, plus new enterprise discussions in regulated industries that value strong identity verification.

However, the safe harbor language reiterates risks such as a history of losses, need for additional capital, going concern uncertainties, competitive pressures in biometric IAM, geopolitical exposure, and compliance with SEC and Nasdaq requirements. Future filings covering results for the period ending June 30, 2026 will show how closely actual performance tracks this outlook.

Item 2.02 Results of Operations and Financial Condition Financial
Disclosure of earnings results, typically an earnings press release or preliminary financials.
Item 9.01 Financial Statements and Exhibits Exhibits
Financial statements, pro forma financial information, and exhibit attachments filed with this report.
Expected revenue growth 50% increase First half of 2026 revenues vs prior-year first half
Hardware contracts More than $1M Contracts for Pocket 10 Finger Scanners and Mobile POS Pro in Q1 and Q2 2026
Users secured Over forty million users PortalGuard IAM and biometric authentication deployments
Identity and Access Management financial
"a global leader in Identity and Access Management (IAM) and biometric authentication technologies"
Identity and access management is the set of tools and processes that verify who a person or device is and control what digital resources they can use, like a company’s system for issuing security badges and setting which doors each badge opens. It matters to investors because strong identity controls reduce the chance of costly data breaches, regulatory fines and downtime, protect customer trust, and can lower IT costs and operational risk.
biometric authentication technical
"an opportunity to deploy our biometric authentication technology with a foreign tax agency"
Biometric authentication uses a person’s unique physical or behavioral traits—such as fingerprints, facial features, iris patterns, or voice—to verify identity instead of passwords or codes. For investors, it matters because faster, more secure login methods can boost customer trust and reduce fraud-related costs, while also creating opportunities and risks around technology adoption, data privacy rules, and the companies that build or supply the biometric systems.
annually recuring software licenses and services revenues financial
"Building on our growing base of annually recuring software licenses and services revenues"
forward-looking statements regulatory
"All statements contained in this press release other than statements of historical facts are "forward-looking statements""
Forward-looking statements are predictions or plans that companies share about what they expect to happen in the future, like estimating sales or profits. They matter because they help investors understand a company's outlook, but since they are based on guesses and assumptions, they can sometimes be wrong.
going concern financial
"our ability to continue as a going concern"
A going concern is a business that is expected to continue its operations and meet its obligations for the foreseeable future, rather than shutting down or selling off assets. This assumption matters to investors because it indicates stability and ongoing profitability, making the business a more reliable investment. Think of it as believing a restaurant will stay open and serve customers, rather than closing down suddenly.
internal controls over financial reporting regulatory
"unable to continue to maintain effective internal controls over financial reporting"
Internal controls over financial reporting are the policies, procedures and checks a company uses to make sure its accounting and financial statements are accurate, complete and free from significant error or fraud. They matter to investors because strong controls lower the risk of misleading results or surprise restatements—think of them as a quality checkpoint on a factory line that helps prevent costly defects that could damage a company’s value and reputation.
Revenue 50% increase expected +50% vs prior-year first half
Profitability Profitable in 1H 2026 Improvement from historical losses
Guidance

Company expects 50% revenue growth and profitability in the first half of 2026, supported by recurring software licenses and more than $1M in biometric hardware contracts.

false 0001019034 0001019034 2026-04-16 2026-04-16
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
 
Washington, D.C. 20549
 
FORM 8-K
 
CURRENT REPORT
 
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
 
Date of Report (Date of earliest event reported): April 16, 2026
 
BIO-key International, Inc.
(Exact name of registrant as specified in its charter)
 
 
Delaware
(State or other jurisdiction of incorporation)
1-13463
(Commission File Number)
41-1741861
(I.R.S. Employer Identification No.)
 
101 CRAWFORDS CORNER ROAD, SUITE 4116,
HOLMDEL, NJ 07733
(Address of principal executive offices)
 
(732) 359-1100
(Registrant’s telephone number, including area code)
 
Securities registered pursuant to Section 12(b) of the Act:
 
Title of each class Trading Symbol(s) Name of each exchange on which registered
Common Stock BKYI Nasdaq Capital market
   
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2 below):
 
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
Pre-commencement communications pursuant to Rule 13e-4(c) under Exchange Act (17 CFR 240.13e-4(c))
 
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR 240.12b-2).
 
    Emerging growth company
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
 
 

 
Item 2.02.         Results of Operations and Financial Condition.
 
On April 16, 2026, BIO-key International, Inc. (the “Company”) issued a press release which included information about its results of operations for its first quarter ended March 31, 2026. A copy of the press release issued by the Company on April 16, 2026 is attached as Exhibit 99.
 
The information, including the exhibit attached hereto, in this Current Report on Form 8-K shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that Section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, except as otherwise expressly stated in such filing.
 
 
Item 9.01.         Financial Statements, Pro Forma Financial Information and Exhibit.
 
(d)
Exhibits. The following exhibit is furnished herewith:
 
99.1
Press Release, dated April 16, 2026 issued by the Company.
 
104
Cover Page Interactive Data File (embedded within the Inline XBRL document)
 
2

 
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
BIO-KEY INTERNATIONAL, INC.
Date: April 20, 2026
By:
/s/ Cecilia C. Welch
Cecilia C. Welch
Chief Financial Officer
 
 

 
EXHIBIT INDEX
 
Exhibit No.              Description
 
99.1
Press Release, dated April 16, 2026, issued by the Company.
 
 

Exhibit 99.1

 

image01.jpg

 

 

BIO-key Expects 50% Increase in First Half Revenues, Driving Profitability in the Period

 

Holmdel, NJ April 16, 2026 BIO-key® International, Inc. (Nasdaq: BKYI), a global leader in Identity and Access Management (IAM) and biometric authentication technologies, previewed today its business outlook for the first half of 2026 (1H’26) ending June 30, 2026, supported by building software license momentum and strength in hardware revenues.

 

Expected 1H26 Results:

1H’26 revenues expected to grow 50% to approximately $5M vs. $3.3M in 1H’25

Positive net income expected in 1H’26 vs. $1.9M net loss in 1H’25

Cash position at the close of 1H’26 is expected to remain in line with $2.7M at year-end 2025

 

Q126 & Q226 Expected Revenues:

Q1’26 revenues expected to grow 37% to $2.2M vs. $1.6M in Q1’25

Q2’26 revenues expected to grow 65% to $2.8M vs. $1.7M in Q2’25

 

BIO-key’s improved 1H’26 results reflect the benefit of a $1.04M expanded, one-year software license renewal with a longstanding foreign retail bank customer in Q1’26 and more than $1M in contracts for the company’s Pocket 10 Finger Scanners and Mobile POS Pro point-of-sales devices in Q1 and Q2’26.

 

BIO-key CEO, Mike DePasquale commented, “Our groundwork last year positioned BIO-key for solid top- and bottom-line improvements that are now coming into focus in the first half of 2026. Building on our growing base of annually recuring software licenses and services revenues, we see improving traction with larger contract opportunities which we expect will benefit our results in the second half of 2026 and into 2027. These include an opportunity to deploy our biometric authentication technology with a foreign tax agency and potential deployment with a new foreign defense ministry, in addition to discussions with new enterprise customers, particularly in regulated industries where positive identity is essential.

 

“These developments underscore the demand we are creating directly and via partners, particularly in regions with favorable regulatory frameworks. Through disciplined management of margins and overhead, we expect our top-line growth to translate into meaningful improvement on the net income line and in our ability to fund further growth.”

 

About BIO-key International, Inc. (www.BIO-key.com)

BIO-key is revolutionizing authentication and cybersecurity with biometric-centric, multi-factor identity and access management (IAM) software securing access for over forty million users. BIO-key allows customers to choose the right authentication factors for diverse use cases, including phoneless, tokenless, and passwordless biometric options. Its cloud-hosted or on-premise PortalGuard IAM solution provides cost-effective, easy-to-deploy, convenient, and secure access to computers, information, applications, and high-value transactions.

 

 

 

BIO-key Safe Harbor Statement

All statements contained in this press release other than statements of historical facts are "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995 (the "Act"). The words "estimate," "project," "intends," "expects," "anticipates," "believes" and similar expressions are intended to identify forward-looking statements. Such forward-looking statements are made based on management's beliefs, as well as assumptions made by, and information currently available to, management pursuant to the "safe-harbor" provisions of the Act. These statements are not guarantees of future performance or events and are subject to risks and uncertainties that may cause actual results to differ materially from those included within or implied by such forward-looking statements. These risks and uncertainties include, without limitation, our history of losses and limited revenue; our ability to raise additional capital to satisfy working capital needs; our ability to continue as a going concern; our ability to protect our intellectual property; changes in business conditions; changes in our sales strategy and product development plans; changes in the marketplace; continued services of our executive management team; security breaches; competition in the biometric technology and identity access management industries; market acceptance of biometric products generally and our products under development; our ability to convert sales opportunities to customer contracts; our ability to expand into Asia, Africa and other foreign markets; our ability to migrate Swivel Secure customers to BIO-key and Portal Guard offerings; our ability to execute definitive agreements with Fiber Food Systems and/or its customers to utilize our access management solutions; our ability to integrate our solutions into any of Fiber Food System’s offerings; fluctuations in foreign currency exchange rates; the duration and extent of continued hostilities in Ukraine and its impact on our European customers; the impact of tariffs and other trade barriers which may make it more costly for us to import inventory from China and Hong Kong and certain product components from South Korea; delays in the development of products, the commercial, reputational and regulatory risks to our business that may arise as a consequence of non-compliance with Securities and Exchange Commission (“SEC”) and Nasdaq periodic reporting requirements; our temporary loss of the use of a Registration Statement on Form S-3 to register securities in the future; any disruption to our business that may occur on a longer-term basis should we be unable to continue to maintain effective internal controls over financial reporting, and statements of assumption underlying any of the foregoing as well as other factors set forth under the caption "Risk Factors" in our Annual Report on Form 10-K for the year ended December 31, 2024 and other filings with the SEC. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date made. Except as required by law, we undertake no obligation to disclose any revision to these forward-looking statements whether as a result of new information, future events, or otherwise.

 

Engage with BIO-key

Facebook – Corporate: https://www.facebook.com/BIOkeyInternational/
LinkedIn – Corporate: https://www.linkedin.com/company/bio-key-international
X – Corporate: @BIOkeyIntl
X – Investors: @BIO_keyIR
StockTwits: BIO_keyIR

 

Investor Contacts

William Jones, David Collins

Catalyst IR

BKYI@catalyst-ir.com or 212-924-9800

 

 

FAQ

What revenue growth is BIO-key (BKYI) expecting for the first half of 2026?

BIO-key expects a 50% increase in first-half 2026 revenues. This growth outlook is driven by stronger software license momentum and expanding hardware sales as the period ending June 30, 2026 progresses.

Is BIO-key (BKYI) projecting profitability in the first half of 2026?

Yes, BIO-key expects to be profitable for the first half of 2026. Management links this to higher revenues, better margins, disciplined overhead control, and a growing base of annually recurring software license and services revenues.

What contracts support BIO-key’s (BKYI) 1H 2026 outlook?

The outlook is supported by a one-year software license renewal with a longstanding foreign retail bank and more than $1M in contracts for Pocket 10 Finger Scanners and Mobile POS Pro point-of-sales devices in the first two quarters of 2026.

Which future opportunities does BIO-key (BKYI) highlight in its outlook?

BIO-key highlights potential deployments of its biometric authentication technology with a foreign tax agency and a new foreign defense ministry, along with discussions with new enterprise customers, especially in regulated industries where positive identity verification is critical.

What key risks does BIO-key (BKYI) mention alongside its 2026 outlook?

BIO-key cites risks including its history of losses, need for additional capital, ability to continue as a going concern, competitive biometric and IAM markets, geopolitical and tariff impacts, and compliance with SEC and Nasdaq reporting and internal control requirements.

How many users does BIO-key (BKYI) say its IAM solutions secure?

BIO-key states that its biometric-centric identity and access management software secures access for over forty million users. The company offers cloud-hosted or on-premise PortalGuard IAM solutions for secure, convenient access to systems, applications, and high-value transactions.

Filing Exhibits & Attachments

5 documents